Risk factor
Negligible price volatility
Profitability factor
Very strong margins and returns
About
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent...
Company Valuation
Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA,
Target Price
The average target price of ZTS is 148 and suggests 19% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
Buy
Sell